What Concentrations Do Compounded GLP-1 Vials Come In?

Concentration tells you how many milligrams of active medication are dissolved in each milliliter of solution. It is expressed as mg/mL. A vial labeled 5 mg/mL contains 5 milligrams of medication in every 1 milliliter of liquid.

Concentration directly determines how many units you draw on a U-100 syringe for a given milligram dose. Higher concentrations mean smaller injection volumes for the same dose. Lower concentrations mean larger injection volumes but can make it easier to measure very small doses accurately.

Compounding pharmacies produce semaglutide at four common concentrations:

1 mg/mL: Lowest concentration. Best for patients on very small initiation doses (0.125 mg to 0.25 mg) where precise measurement matters. Requires higher injection volumes at maintenance doses.

2 mg/mL: A mid-range option. Balances measurement precision with reasonable injection volumes for both initiation and maintenance doses.

2.5 mg/mL: Frequently prescribed. Works well across the full dose range from 0.25 mg (10 units) through 1.0 mg (40 units).

5 mg/mL: Highest common concentration. Keeps injection volumes very small, even at higher maintenance doses like 2.0 mg (40 units) or 2.4 mg (48 units). Requires careful measurement for small initiation doses, as 0.25 mg is only 5 units.

Tirzepatide doses are higher in milligrams than semaglutide, so compounding pharmacies use higher concentrations:

5 mg/mL: Entry-level concentration. Suitable for the 2.5 mg initiation dose (50 units) but produces large injection volumes at higher doses.

10 mg/mL: A versatile option. The 2.5 mg starting dose requires 25 units, and even 10 mg requires only 100 units (1 mL).

20 mg/mL: Common for patients on moderate to high doses. Keeps volumes manageable even at 15 mg (75 units).

30 mg/mL: Highest concentration. Best for patients on higher maintenance doses like 10 mg (33 units) or 15 mg (50 units). The 2.5 mg initiation dose is only 8.3 units, which can be difficult to measure precisely.

Your compounded GLP-1 vial label contains several critical pieces of information. Look for the medication name (semaglutide or tirzepatide), the concentration in mg/mL, the total volume of the vial, the beyond-use date (expiration), and storage instructions.

The concentration is typically printed prominently, often after the medication name. For example: "Semaglutide Injection 5 mg/mL" or "Tirzepatide 20 mg/mL." Some labels may also list the total drug content, such as "5 mg/mL — 2 mL vial (10 mg total)."

Always read the concentration before drawing your dose. If you receive a new vial with a different concentration than your previous one, recalculate your units before injecting. When in doubt, contact your provider or pharmacist.

Your prescribing provider and compounding pharmacy will select a concentration based on your current dose, dose escalation plan, and measurement precision needs. Patients in the early stages of treatment (low doses) may benefit from lower concentrations, while patients on stable maintenance doses often prefer higher concentrations for smaller injection volumes.

Some pharmacies offer only one or two concentrations. If your pharmacy switches your concentration during treatment, recalculate your units carefully. A patient accustomed to drawing 10 units from a 2.5 mg/mL semaglutide vial for a 0.25 mg dose would need only 5 units from a 5 mg/mL vial. Drawing the old 10 units from the new vial would deliver double the intended dose.

This content is for educational purposes. Always verify your vial concentration and unit count with your healthcare provider before each injection.